2026 Q1 Portfolio Activity
In 2026 Q1, Euclidean Capital LLC maintained a portfolio of 12 distinct positions. They heavily accumulated shares in VANGUARD INTL EQUITY INDEX F, increasing the position by 8.5%. Conversely, Euclidean Capital LLC completely exited their position in SPDR S&P 500 ETF TR.
Position History
hover any row below to update
Loading…
Total Positions
12
Quarter
2026 Q1
Top Holding
VEU (62.1%)
Top 10 Concentration
100.0%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
Showing 1-12 of 12
Euclidean Capital LLC Full Holdings List — 2026 Q1
| Stock | History | Sector / Type | Port % | Prev % | Rank / Prev | Conviction | Change | % Change | Influence | Shares | Mkt Value | Avg Cost | Price Held | 1st Owned | Source | Source Date | Date Reported | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
VEU
VANGUARD INTL E...
|
ETF | 62.09% | 59.53% |
#1
Prev: #1
|
8.0 |
—
|
253,400 | 8.5% |
P
S
|
3,243,484 | $243,585,648 |
$63.43
+29.5%
|
2024 Q3 | 13F Filing | 2026-03-31 | 2026-05-15 | ||
|
VTV
VANGUARD INDEX ...
|
ETF | 26.01% | 26.88% |
#2
Prev: #2
|
6.5 |
—
|
no change | no change |
P
S
|
520,000 | $102,024,000 |
$189.94
+10.0%
|
2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | ||
|
INDA
ISHARES TR
|
ETF | 4.41% | 5.41% |
#3
Prev: #3
|
3.8 |
—
|
no change | no change |
P
S
|
369,600 | $17,312,064 |
$41.78
+13.2%
|
2022 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | ||
|
ORIC
ORIC PHARMACEUT...
|
Healthcare | 3.20% | 2.19% |
#4
1
Prev: #5
|
2.8 |
—
|
no change | no change |
P
S
|
989,410 | $12,535,825 | 2020 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
FHTX
FOGHORN THERAPE...
|
Healthcare | 1.92% | 2.30% |
#5
1
Prev: #4
|
2.3 |
—
|
no change | no change |
P
S
|
1,573,761 | $7,522,578 | 2020 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
PMVP
PMV PHARMACEUTI...
|
Healthcare | 0.83% | 0.89% |
#6
Prev: #6
|
1.3 |
—
|
no change | no change |
P
S
|
2,627,643 | $3,258,277 | 2020 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
ALEC
ALECTOR INC
|
Healthcare | 0.72% | 0.55% |
#7
2
Prev: #9
|
1.3 |
—
|
no change | no change |
P
S
|
1,307,858 | $2,811,895 | 2020 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
SRZN
SURROZEN INC
|
Healthcare | 0.65% | 0.54% |
#8
2
Prev: #10
|
1.3 |
—
|
no change | no change |
P
S
|
87,696 | $2,554,584 | 2023 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
TNYA
TENAYA THERAPEU...
|
Healthcare | 0.18% | 0.20% |
#9
2
Prev: #11
|
1.1 |
—
|
no change | no change |
P
S
|
1,015,705 | $703,274 | 2021 Q3 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
SRZNW
SURROZEN INC
|
Unknown | 0.00% | 0.00% |
#10
2
Prev: #12
|
1.0 |
—
|
no change | no change |
P
S
|
170,833 | $2,733 | 2023 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
RAPT
RAPT THERAPEUTI...
|
Healthcare | 0.00% | 0.75% |
Sold All 😨
(Was: #8) |
0.0 |
—
|
-82,234 | -100.0% |
CLOSED
|
— | $— | 2020 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
SPY
SPDR S&P 500 ET...
|
ETF | 0.00% | 0.76% |
Sold All 😨
(Was: #7) |
0.0 |
—
|
-4,104 | -100.0% |
CLOSED
|
— | $— | 2023 Q2 | 13F Filing | 2026-03-31 | 2026-05-15 |
Showing 1-12 of 12 holdings